EP1800693
Viðbótarmeðferð með notkuninni á and-glýpíkan-3-mótefni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.8.2005EP published:
17.7.2013EP application number:
05780979.0
EP translation filed:
2.9.2013Grant published:
15.9.2013EPO information:
European Patent Register
Max expiry date:
22.8.2025Expiry date:
22.8.2024
Title:
ADJUVANT THERAPY WITH THE USE OF ANTI-GLYPICAN 3 ANTIBODY
Timeline
Owner
Name:
CHUGAI SEIYAKU KABUSHIKI KAISHAAddress:
5-1, Ukima 5-chome, Kita-ku, 115-8543, Tokyo, JP
Inventor
Name:
KINOSHITA, YasukoAddress:
Kamakura-shi Kanagawa, JP
Name:
SUGIMOTO, MasamichiAddress:
Kamakura-shi Kanagawa, JP
Name:
OKABE, HisafumiAddress:
Kamakura-shi Kanagawa, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2004244273Date:
24.8.2004Country:
JP
Number:
2005090945Date:
28.3.2005Country:
JP
Classification
Categories:
A61K 39/395, A61P 35/00, C07K 16/30
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 27.8.2013
Expires: 22.8.2014
Payer: Árnason Faktor
Number: 10
Paid: 24.7.2014
Expires: 22.8.2015
Payer: Árnason Faktor
Number: 11
Paid: 23.7.2015
Expires: 22.8.2016
Payer: Árnason Faktor
Number: 12
Paid: 8.8.2016
Expires: 22.8.2017
Payer: Árnason Faktor
Number: 13
Paid: 25.7.2017
Expires: 22.8.2018
Payer: Árnason Faktor
Number: 14
Paid: 6.7.2018
Expires: 22.8.2019
Payer: Árnason Faktor
Number: 15
Paid: 9.7.2019
Expires: 22.8.2020
Payer: Árnason Faktor
Number: 16
Paid: 8.7.2020
Expires: 22.8.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.7.2021
Expires: 22.8.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 5.7.2022
Expires: 22.8.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.7.2023
Expires: 22.8.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.7.2023
Expires: 22.8.2024
Payer: Árnason Faktor ehf.